2/27
04:37 pm
jnj
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]
Low
Report
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]
2/27
06:51 am
jnj
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]
Low
Report
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]
2/26
07:49 pm
jnj
Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]
Low
Report
Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]
2/26
04:14 pm
jnj
AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]
Low
Report
AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]
2/26
02:59 pm
jnj
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]
Low
Report
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]
2/26
02:30 pm
jnj
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
Low
Report
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
2/26
09:07 am
jnj
Are You Looking for a High-Growth Dividend Stock? [Yahoo! Finance]
Low
Report
Are You Looking for a High-Growth Dividend Stock? [Yahoo! Finance]
2/26
07:32 am
jnj
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership [Yahoo! Finance]
Low
Report
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership [Yahoo! Finance]
2/26
05:38 am
jnj
Quantum acquires NeuWave Medical to enhance tumour ablation treatments [Yahoo! Finance]
Low
Report
Quantum acquires NeuWave Medical to enhance tumour ablation treatments [Yahoo! Finance]
2/25
04:02 pm
jnj
Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub [Yahoo! Finance]
Low
Report
Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub [Yahoo! Finance]
2/25
08:25 am
jnj
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer [Yahoo! Finance]
Low
Report
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer [Yahoo! Finance]
2/25
05:33 am
jnj
How Shifting Analyst Targets Are Rewriting The Johnson & Johnson (JNJ) Investment Story [Yahoo! Finance]
Low
Report
How Shifting Analyst Targets Are Rewriting The Johnson & Johnson (JNJ) Investment Story [Yahoo! Finance]
2/24
04:29 pm
jnj
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) [Yahoo! Finance]
Low
Report
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) [Yahoo! Finance]
2/24
04:03 pm
jnj
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
Low
Report
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
2/24
11:02 am
jnj
What Johnson & Johnson (JNJ)'s Prostate Cancer Drug Lawsuit Means For Shareholders [Yahoo! Finance]
Low
Report
What Johnson & Johnson (JNJ)'s Prostate Cancer Drug Lawsuit Means For Shareholders [Yahoo! Finance]
2/24
08:33 am
jnj
Quantum Surgical Announces Acquisition of NeuWave Medical, Inc. [Yahoo! Finance]
Low
Report
Quantum Surgical Announces Acquisition of NeuWave Medical, Inc. [Yahoo! Finance]
2/24
02:02 am
jnj
Bayer sues Johnson & Johnson over prostate cancer drug claims [Seeking Alpha]
Low
Report
Bayer sues Johnson & Johnson over prostate cancer drug claims [Seeking Alpha]
2/23
03:32 pm
jnj
Bayer sues Johnson & Johnson over prostate cancer drug claims [USA TODAY]
Low
Report
Bayer sues Johnson & Johnson over prostate cancer drug claims [USA TODAY]
2/23
02:03 pm
jnj
A Look At Johnson & Johnson (JNJ) Valuation After New Long Term TREMFYA Ulcerative Colitis Data [Yahoo! Finance]
Low
Report
A Look At Johnson & Johnson (JNJ) Valuation After New Long Term TREMFYA Ulcerative Colitis Data [Yahoo! Finance]
2/23
01:24 pm
jnj
Bloomberg Reports Potential Major Asset Sale by Johnson & Johnson (JNJ) [Yahoo! Finance]
Low
Report
Bloomberg Reports Potential Major Asset Sale by Johnson & Johnson (JNJ) [Yahoo! Finance]
2/23
11:20 am
jnj
Bayer sues Johnson & Johnson over marketing of prostate cancer drug [Yahoo! Finance]
Low
Report
Bayer sues Johnson & Johnson over marketing of prostate cancer drug [Yahoo! Finance]
2/22
01:32 pm
jnj
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio [Yahoo! Finance]
Low
Report
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio [Yahoo! Finance]
2/22
09:09 am
jnj
Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus [Seeking Alpha]
Low
Report
Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus [Seeking Alpha]
2/21
08:00 am
jnj
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
Low
Report
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
2/20
09:42 am
jnj
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $210.00. They now have a "neutral" rating on the stock.
Low
Report
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $210.00. They now have a "neutral" rating on the stock.